1. Home
  2. PULM vs SYPR Comparison

PULM vs SYPR Comparison

Compare PULM & SYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PULM
  • SYPR
  • Stock Information
  • Founded
  • PULM 2003
  • SYPR 1997
  • Country
  • PULM United States
  • SYPR United States
  • Employees
  • PULM N/A
  • SYPR N/A
  • Industry
  • PULM Biotechnology: Pharmaceutical Preparations
  • SYPR Industrial Machinery/Components
  • Sector
  • PULM Health Care
  • SYPR Industrials
  • Exchange
  • PULM Nasdaq
  • SYPR Nasdaq
  • Market Cap
  • PULM 33.2M
  • SYPR 36.8M
  • IPO Year
  • PULM N/A
  • SYPR 1994
  • Fundamental
  • Price
  • PULM $7.43
  • SYPR $1.96
  • Analyst Decision
  • PULM
  • SYPR
  • Analyst Count
  • PULM 0
  • SYPR 0
  • Target Price
  • PULM N/A
  • SYPR N/A
  • AVG Volume (30 Days)
  • PULM 34.2K
  • SYPR 52.5K
  • Earning Date
  • PULM 08-12-2025
  • SYPR 08-12-2025
  • Dividend Yield
  • PULM N/A
  • SYPR N/A
  • EPS Growth
  • PULM N/A
  • SYPR N/A
  • EPS
  • PULM N/A
  • SYPR N/A
  • Revenue
  • PULM $1,921,000.00
  • SYPR $134,135,000.00
  • Revenue This Year
  • PULM N/A
  • SYPR N/A
  • Revenue Next Year
  • PULM $134.88
  • SYPR N/A
  • P/E Ratio
  • PULM N/A
  • SYPR N/A
  • Revenue Growth
  • PULM N/A
  • SYPR N/A
  • 52 Week Low
  • PULM $1.78
  • SYPR $1.30
  • 52 Week High
  • PULM $10.40
  • SYPR $3.72
  • Technical
  • Relative Strength Index (RSI)
  • PULM 49.28
  • SYPR 52.77
  • Support Level
  • PULM $8.49
  • SYPR $1.96
  • Resistance Level
  • PULM $8.75
  • SYPR $2.23
  • Average True Range (ATR)
  • PULM 0.42
  • SYPR 0.16
  • MACD
  • PULM -0.14
  • SYPR -0.00
  • Stochastic Oscillator
  • PULM 0.11
  • SYPR 21.74

About PULM Pulmatrix Inc.

Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

About SYPR Sypris Solutions Inc.

Sypris Solutions Inc is a USA-based company engaged in providing truck components, oil and gas pipeline components, and aerospace and defense electronics. The company offers a range of manufacturing, engineering, design, and other technical services. The business activity of the firm is functioned through Sypris Technologies and Sypris Electronics segments. Sypris Technologies segment is engaged in the sales of machined, welded, and heat-treated steel components for heavy commercial vehicle and high-pressure energy pipeline applications whereas the Sypris Electronics segment is engaged in the sale of manufacturing services, technical services, and products to customers in the market for aerospace and defense electronics. Sypris derives the revenue from the Technologies segment.

Share on Social Networks: